首页> 外文期刊>China National Journal of New Gastroenterology >p53 gene mutations in primary gastric cancer
【24h】

p53 gene mutations in primary gastric cancer

机译:原发性胃癌中p53基因突变

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS p53 gene is one of the focuses in the study of tumour suppressor genes. So far, there is still controversy about the relationship between p53 alterations and clinicolpathological parameters of gastic cancers such as macroscopic classification, stage, degree of differentiation, depth of tumour invasion and lymphonod metastasis. Tamura has reported that p53 gene mutations mainly occur in the aneuploid tumours. But in China, nothing is reported in this field of study. Our aim is to analyze the relationship between p53 gene mutations and these parameters including DNA ploidy in Chinese primary gasrtic cancers. METHODS Mutations of the p53 gene in exon5 - 8 were examined in 20 cases of primary gasric cancer by PCR - SSCP (Polymerase - chain - reaction - single - strand - conformation - polymorphism)analysis. RESULTS Mutations were detected in 8(40%) cases: 2 cases in exonS- 6, 2 cases in exon? , 4 cases in exonS.These mutations were detected from stage 0 to stage Ⅲ. No significant association was found between p53 gene mutations and the clinicopathdogical parameters such as macroscopic classification , degree of histological differentiation , depth of tumour invasion and lymphonod metastasis. In addition, 66.7% (6 of 9) of aneuploid tumours had p53 mutations and only 18.2% (2 of 11 )of diploid tumours had mutations. CONCLUSIONS These results suggest that p53 gene mutations are related to DNA ploidy alterations and that p53 gene is one of the important tumour suppressor genes in human gastric cancer.
机译:AIMS p53基因是肿瘤抑制基因研究的重点之一。迄今为止,关于p53改变与胃癌临床病理参数之间的关系仍存在争议,例如宏观分类,分期,分化程度,肿瘤浸润深度和淋巴结转移。田村报道了p53基因突变主要发生在非整倍体肿瘤中。但是在中国,这一研究领域没有任何报道。我们的目的是分析中国原发性胃癌中p53基因突变与这些参数(包括DNA倍性)之间的关系。方法采用PCR-SSCP(聚合酶-链反应-单链-构象-多态性)分析方法检测20例原发性胃癌外显子5-8中p53基因的突变。结果在8(40%)例中检测到突变:外显子6例2例,外显子2例?外显子4例。从0期到Ⅲ期检测到这些突变。 p53基因突变与临床病理参数如宏观分类,组织学分化程度,肿瘤浸润深度和淋巴结转移之间无显着相关性。此外,非整倍体肿瘤中有66.7%(9个中的6个)具有p53突变,而二倍体肿瘤中只有18.2%(11个中的2个)具有突变。结论这些结果表明p53基因突变与DNA倍性改变有关,并且p53基因是人胃癌中重要的抑癌基因之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号